HOME >> BIOLOGY >> NEWS
Cholesterol Lowering Drugs Stall Disease Progression In People With Below-Average Blood Cholesterol Level

is a widely used noninvasive technique to measure atherosclerosis in the carotid arteries. The degree of narrowing in the carotids is an indication of the amount of atherosclerosis elsewhere in the body. From the scans, the researchers could measure the thickness of the carotid artery wall; an increase in artery thickness over time indicated an increase in atherosclerotic deposits. At the end of four years, 77 percent of the pravastatin and 78 percent of the placebo patients remained in the study. The New Zealand researchers found that the pravastatin group had average total cholesterol of about 39 mg/dL (19 percent) lower than the placebo group. The average increase in carotid artery thickness was 0.048 millimeters (0.00187 inch) in the placebo group and a decrease in thickness of 0.014 millimeters (0.00055 inch) in the pravastatin group. "There was clearly a major difference between the two groups," MacMahon says. "We showed that cholesterol lowering with pravastatin appeared to prevent the progression of atherosclerosis in the carotid artery."

The effect of treatment was the same for those with above-average levels as those with average or below-average levels, according to MacMahon.

The drug group also had 27 percent lower "bad" low-density lipoprotein cholesterol, which is involved in building up artery deposits, and a 19 percent lower apolipoprotein B, a protein associated with "bad" cholesterol. The drug group also had a 13 percent lower level of triglycerides, the chemical form of fat in most foods; four percent higher apolipoprotein A1, a protein that appears to increase heart attack risk; and four percent higher "good" high-density lipoprotein cholesterol, which carries cholesterol away from blood vessel walls.

Does this study indicate that lowering cholesterol with a low fat diet also will prevent atherosclerosis? "Certainly, we would hope that cholesterol lower
'"/>

Contact: Carole Bullock
caroleb@amhrt.org
214-706-1279
American Heart Association
11-May-1998


Page: 1 2 3

Related biology news :

1. Cholesterol lowering drug effective in treating most common form of multiple sclerosis
2. Cholesterol-independent benefits of statins in cardiac hypertrophy
3. Cholesterol levels not necessarily indicative of cardiac health
4. Women With Low Cholesterol May Be At Risk For Depression And Anxiety
5. Structure Of HDL Cholesterol Determined
6. Discovery Of A Molecule That Controls Bile Acids May Lead To New Cholesterol Drugs
7. Researchers Learn How Nature Produces Cholesterol-Lowering Lovastatin
8. New Insights About Good Cholesterol
9. New Gene May Play Important Role In Regulating HDL, The Good Cholesterol
10. Chinese Condiment Cuts Blood Cholesterol
11. Blue-Green Algae Has Dual Cholesterol Lowering Abilities

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/4/2019)... ... April 02, 2019 , ... Orbsen ... stromal cell immunotherapies, announced it will move its base of operations from the ... the University’s newly created biotechnology park in Galway, Ireland. , “With four clinical ...
(Date:4/1/2019)... ... ... Stay on top of current hot topics through free webinars presented by leading experts ... so be sure to register today to save your place! Participate in the discussion ... upcoming webinars: , CLINICAL TRIALS , April 2 – They’re Talking. Are You Listening? ...
(Date:3/29/2019)... ... March 29, 2019 , ... GenCure has selected G-CON Manufacturing, ... facility. The new facility, which will anchor the VelocityTX innovation center in San ... manufacturing capabilities to support clinical cell therapy trials. GenCure is a subsidiary of ...
Breaking Biology News(10 mins):
(Date:4/8/2019)... ... April 08, 2019 , ... CallTower, a ... the launch of their app integration solution, CT Cloud Unite. CT Cloud ... while using CT Cloud Voice and Skype for Business solutions. This robust integration ...
(Date:4/4/2019)... BOSTON (PRWEB) , ... April 03, 2019 , ... ... leaders together through intimate off-the-record collaboration and dialogue, today announces its Boston CEO ... CEO offers insights into the industry’s challenges and opportunities with high-level panels and ...
(Date:3/27/2019)... ... 27, 2019 , ... Lachman is sponsoring the event on April 1-4, where ... Ireland. The executive team on site will be available to discuss strategies and tactics ... agenda this year. , Executives from Lachman participating at this year’s conference include Fran ...
(Date:3/19/2019)... ... March 19, 2019 , ... Cirrascale Cloud ... it has extended its managed services offering to include NVIDIA® DGX™ systems. The ... part of the NVIDIA DGX-Ready Data Center program to deliver a Zero DevOps ...
Breaking Biology Technology:
Cached News: